| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/10/1997 | US5637580 Antimicrobial penem-quinolones |
| 06/10/1997 | US5637579 Beta-lactamase inhibitors; bactericides |
| 06/10/1997 | US5637577 Treatment of potozoal diseases |
| 06/10/1997 | US5637572 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 06/10/1997 | US5637571 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
| 06/06/1997 | CA2191924A1 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production |
| 06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
| 06/05/1997 | WO1997019947A1 2'-[[4'-HALO-[1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO[CYCLOPENTANE-1,7'(8'H)-[3H]IMIDAZO[2,1-b]PURIN]-4'(5'H)-ONES |
| 06/05/1997 | WO1997019942A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 06/05/1997 | WO1997019940A1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
| 06/05/1997 | WO1997019928A1 Salts of quinoline derivatives as nk3 antagonists |
| 06/05/1997 | WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | WO1997019687A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | WO1997019685A1 The use of cholinesterase inhibitors in the treatment of xerostomia |
| 06/05/1997 | WO1997019679A2 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 06/05/1997 | WO1997019678A1 Improved perfluorocarbons for biological gas exchange and method |
| 06/05/1997 | WO1997019669A2 Heterocyclic compounds and their use |
| 06/05/1997 | WO1997012036A3 Bone stimulating factor |
| 06/05/1997 | WO1997009973A3 Peripherally active anti-hyperalgesic opiates |
| 06/05/1997 | DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/05/1997 | CA2239206A1 Methods of production and use of liquid formulations of plasma proteins |
| 06/05/1997 | CA2238555A1 Heterocyclic compounds and their use |
| 06/05/1997 | CA2238312A1 Salts of quinoline derivatives as nk3 antagonists |
| 06/05/1997 | CA2237956A1 2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776907A2 Process for producing platelet factor-4 |
| 06/04/1997 | EP0776896A1 Heterocyclic compounds and their use |
| 06/04/1997 | EP0776895A1 Protein kinase C inhibitor |
| 06/04/1997 | EP0776663A1 Remedy for myotonic dystrophy |
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776326A1 Pyrrolinone-based peptidomimetics |
| 06/04/1997 | EP0776325A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 06/04/1997 | EP0776324A1 Endothelin antagonists |
| 06/04/1997 | EP0776323A1 Salts of an anti-migraine indole derivative |
| 06/04/1997 | EP0776215A1 Device for delivery of substances and methods of use thereof |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0776201A1 Composition and method for treating anxiety |
| 06/04/1997 | EP0776200A1 Composition and method for protection against drug dependency |
| 06/04/1997 | EP0776182A1 Therapeutic use of acetazolamide for the treatment of brain edema |
| 06/04/1997 | EP0697859B1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 06/04/1997 | CN1151157A Metalloproteinase inhibitors |
| 06/04/1997 | CN1151119A Medical use of bromelain |
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1151115A Topical compositions comprising N-acetyl-L-cysteine |
| 06/04/1997 | CN1150947A Alkenyl-benzoyl guanidine derivant |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035055C Process for preparaing unsaturated 17-'beta' substituted 3-carboxysteroids |
| 06/04/1997 | CN1035054C Novel isoxazolines as antiinflammatory agents |
| 06/03/1997 | US5635516 (Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents |
| 06/03/1997 | US5635515 Administering cinchonine and/or hydroquinidine |
| 06/03/1997 | US5635513 6-fluoro-2,3,4,5-tetrahydro-5-methyl-2[(5-methyl-1H-imidazol-4yl)methyl]-1H-pyrido[4,3-b]in |
| 06/03/1997 | US5635509 Asthma; bronchodilator agents; vasodilation microvascular permeability; mast cells |
| 06/03/1997 | US5635504 Diazepine containing dual action inhibitors |
| 06/03/1997 | US5635503 Dihydropyridine npy antagonists: piperazine derivatives |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
| 06/03/1997 | US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding |
| 06/03/1997 | US5635372 BMP-15 compositions |
| 06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
| 06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | CA2004350C Propenone oxime ethers, a method of preparing them, and pharmaceutical compositions containing them |
| 05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997019102A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | WO1997019101A1 Novel grb2 associating polypeptides and nucleic acids encoding therefor |
| 05/29/1997 | WO1997019084A1 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/29/1997 | WO1997019075A1 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 05/29/1997 | WO1997019074A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 05/29/1997 | WO1997019070A1 Tricyclic spiro compounds as 5ht1d receptor antagonists |
| 05/29/1997 | WO1997019064A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 05/29/1997 | WO1997019063A1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 05/29/1997 | WO1997019062A1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 05/29/1997 | WO1997019060A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
| 05/29/1997 | WO1997019059A1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/29/1997 | WO1997019055A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 05/29/1997 | WO1997019053A1 Metalloproteinase inhibitors |
| 05/29/1997 | WO1997019052A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 05/29/1997 | WO1997019050A1 Synthesis of carboxylic acid derivatives |
| 05/29/1997 | WO1997018834A1 Therapeutic fragments of von willebrand factor |
| 05/29/1997 | WO1997018829A1 Cartilage/bone inducing materials for reparation |
| 05/29/1997 | WO1997018813A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | WO1997018809A1 Protein kinase c inhibitor |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2249343A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | CA2238310A1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 05/29/1997 | CA2238081A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2237016A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 05/29/1997 | CA2234240A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775492A1 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in skin composition |
| 05/28/1997 | EP0775488A1 Stable pharmaceutical composition on the basis of acetylsalicyclic acid and tocopherol |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |